文献速递头颈外科

基于吸烟史的头颈癌遗传与分子差异

Genetic and Molecular Differences in Head and Neck Cancer Based on Smoking History.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2025-01-01

这项回顾性队列研究利用癌症基因组图谱数据,比较有吸烟史与无吸烟史的头颈鳞状细胞癌患者在单核苷酸变异、拷贝数改变、DNA甲基化和mRNA表达上的差异。结果显示吸烟者11q13染色体9个基因拷贝数改变显著富集,FADD和CTTN在非吸烟者中高甲基化,FADD改变与吸烟者死亡风险升高相关。

要点

  • 吸烟者11q13染色体9个基因拷贝数改变显著富集(FDR 0.044-0.046)。
  • 非吸烟者中FADD和CTTN基因显著高甲基化。
  • 吸烟者中FADD改变者死亡风险较高(HR 1.40;95%CI 1.004-1.96)。

核心结论

  • 结果提示,基于吸烟史,HNSCC患者可能存在模式化的遗传与分子差异,尤其是位于染色体11q13的基因。
  • 这些由吸烟导致的基因组差异使吸烟成为影响HNSCC结局的可改变危险因素。

研究设计与样本

  • 回顾性队列研究,纳入癌症基因组图谱(通过cBioPortal)中确诊为HNSCC的患者,不区分HPV状态。
  • 共纳入511例参与者,其中女性135例(26.4%),平均(SD)年龄60.8(11.9)岁。
  • 吸烟者389例(76.1%),非吸烟者122例(23.9%)。

主要发现

  • 吸烟者相比非吸烟者,11q13染色体上9个基因的拷贝数改变显著富集(FDR 0.044-0.046)。
  • 非吸烟者中FADD和CTTN两个基因显著高甲基化;吸烟者中PPFIA1、FGF19、CCND1和LTO1的mRNA高表达。
  • FADD mRNA表达与FADD DNA甲基化呈负相关:非吸烟者Pearson r=-0.53(95%CI -0.59至-0.49),吸烟者Pearson r=-0.57(95%CI -0.63至-0.51)。
  • 吸烟者中FADD改变者相比FADD未改变者死亡风险更高(HR 1.40;95%CI 1.004-1.96)。
  • 通路分析显示显著基因共同参与细胞过程和生物调节,包括嗅觉信号和PI3K/AKT网络。

关键数值与推荐

  • 统计显著性以FDR≤0.05为阈值。
  • 通路富集分析使用Panther分类系统和Reactome通路数据集,采用Fisher精确检验。
  • 生存关联分析采用对数秩检验。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Up to 80% of survivors of head and neck squamous cell carcinoma (HNSCC) currently or previously smoked. Thus, tobacco use is a major modifiable risk factor for HNSCC, even in the era of human papillomavirus (HPV)-associated disease. However, how smoking underlies chromosomal and epigenetic changes that are associated with HNSCC outcomes remains unclear. OBJECTIVE: To characterize genetic and molecular differences and associated biological pathways in patients with HNSCC based on smoking history. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included patients with a confirmed diagnosis of HNSCC from the Cancer Genome Atlas via cBioPortal data independent of HPV status. Data were analyzed between April 2023 and May 2024. MAIN OUTCOMES AND MEASURES: Smoking history was defined as individuals who smoked (currently or previously) compared with nonsmokers (never smoked). Genetic and molecular differences of interest were single nucleotide variation, copy number alteration, DNA methylation, and messenger RNA (mRNA) expression. Accounting for multiple testing, we reported the false discovery rate (FDR), with a statistically significant FDR of 0.05 or less. Potential functions and pathways were investigated using the Panther classification system, and the Fisher exact test was used for overrepresentation, using the Reactome pathway dataset as a guide. Associations between smoking-related genetic alterations and overall survival were analyzed using log-rank tests. RESULTS: Of 511 participants, 135 (26.4%) were female, and the mean (SD) age was 60.8 (11.9) years. People who smoked (389 [76.1%]) demonstrated significantly enriched copy number alterations on 9 genes located on chromosome 11q13 compared with nonsmokers (122 [23.9%]; FDR, 0.044-0.046). Two genes, FADD and CTTN, were significantly highly methylated in nonsmokers. Also, PPFIA1, FGF19, CCND1 and LTO1 were highly expressed in mRNA in those who smoked, while FADD mRNA expression was negatively correlated with FADD DNA methylation in nonsmokers (Pearson r = -0.53; 95% CI, -0.59 to -0.49) and those who smoked (Pearson r = -0.57; 95% CI, -0.63 to -0.51). People who smoked with altered FADD had higher risk of dying than those with FADD unaltered (hazard ratio, 1.40; 95% CI, 1.004-1.96). Pathway analysis showed the significant genes were collectively associated with cellular processes and biological regulations, including olfactory signaling and the PI3K/AKT network. CONCLUSION AND RELEVANCE: The results of this cohort study suggest that there may be patterned genetic and molecular differences in patients with HNSCC based on smoking history, especially genes located on chromosome 11q13. These genomic differences due to smoking make smoking a modifiable risk factor for HNSCC outcomes.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Jiang R, Gao MZ, Chen M, et al. Genetic and Molecular Differences in Head and Neck Cancer Based on Smoking History. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40048195. doi:10.1001/jamaoto.2024.5409

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。